Subarachnoid Hemorrhage

• FDA approval · 2024-08-28
  FDA Approved: NYMALIZE — Supplemental Application (Azurity Pharmaceuticals, Inc.)

  The FDA approved a supplemental application for NYMALIZE (nimodipine) from Azurity Pharmaceuticals, Inc.

• FDA approval · 2024-07-09
  FDA Approved: NIMODIPINE — Original Application (Camber Pharmaceuticals, Inc.)

  FDA approves Camber Pharmaceuticals' original generic application for nimodipine, a calcium channel blocker used to reduce risk of cerebral …

• FDA approval · 2020-12-18
  FDA Approved: NYMALIZE — Supplemental Application (Azurity Pharmaceuticals, Inc.)

  FDA approved a supplemental application for NYMALIZE (nimodipine) by Azurity Pharmaceuticals, Inc. related to the existing nimodipine NDA (N…

• FDA approval · 2019-12-28
  FDA Approved: NYMALIZE — Supplemental Application (Azurity Pharmaceuticals, Inc.)

  FDA approved a supplemental application for NYMALIZE (nimodipine) by Azurity Pharmaceuticals, Inc.

• FDA approval · 2015-08-26
  FDA Approved: NYMALIZE — Supplemental Application (Azurity Pharmaceuticals, Inc.)

  FDA approved a supplemental application for NYMALIZE (nimodipine) by Azurity Pharmaceuticals, Inc.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2015-08-07
  FDA Approved: NYMALIZE — Supplemental Application (Azurity Pharmaceuticals, Inc.)

  FDA approved a supplemental application for NYMALIZE (nimodipine) from Azurity Pharmaceuticals, Inc.

• FDA approval · 2013-06-21
  FDA Approved: NIMODIPINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

  The FDA approved a supplemental application for nimodipine from Heritage Pharmaceuticals (Avet), marking approval of an additional generic p…

• FDA approval · 2013-05-10
  FDA Approved: NYMALIZE — Original Application (Azurity Pharmaceuticals, Inc.)

  FDA approves NYMALIZE (nimodipine) from Azurity Pharmaceuticals in an original NDA (NDA203340). The product is indicated for use in subarach…

• FDA approval · 2008-01-17
  FDA Approved: NIMODIPINE — Original Application (BIONPHARMA INC.)

  FDA approves Bionpharma's nimodipine generic under an original ANDA, enabling market entry for this calcium channel blocker. Nimodipine is i…

• FDA approval · 2007-05-02
  FDA Approved: NIMODIPINE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

  FDA approved the original application for nimodipine as a generic product from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.…